Imagene

Imagene is at the forefront of transforming cancer diagnostics through the power of artificial intelligence. Specializing in medical and diagnostic laboratories, Imagene is dedicated to providing immediate oncology intelligence, overcoming traditional barriers to precision medicine. The company's innovative technology rapidly profiles a wide array of cancer biomarkers from digitized biopsy images, enabling faster and more accurate molecular profiling that evolves genomics, proteomics, and spatial insights.

Imagene's capabilities extend to classifying patterns undetectable by the human eye, facilitating better patient stratification for clinical trials, and discovering novel targets for new drugs. With its headquarters at 2400 Market Street, No. 200, Philadelphia, PA 19103, US, and an additional location at Yitzhak Sadeh 17, Tel Aviv, IL, Imagene collaborates with leading medical centers and pharmaceutical companies globally to advance cancer treatment.

Imagene is committed to innovation and excellence in the fight against cancer. Information is being enhanced and completed with the support of Imagene's management team to ensure the most accurate and up-to-date details are available. We invite the manager of Imagene to create a customized and exclusive company showcase and product listing on our platform to further amplify Imagene's reach and impact.